Silvia Díaz-Cerezo

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Glycemic Control

Clinical Practice

Rheumatoid Arthritis Patients

Cardiovascular Disease

Top Venues

Advances in therapy

Future oncology (London, England)

Diabetes therapy : research, treatment and education of diabetes and related disorders

Endocrinology, diabetes & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Francisco Javier Ampudia-Blasco, Natalia Duque, Esther Artime, Elena Caveda, Erik Spaepen, Silvia Díaz-Cerezo, Miriam Rubio- de Santos, Daniel Callejo Velasco, Mª Pilar Bahíllo-Curieses
Which people with diabetes are treated with a disposable, half-unit insulin pen? A real-world, retrospective, database study in Spain. Endocrinology, diabetes & metabolism (2023)
Beatriz Joven, Concepción Fito Manteca, Esteban Rubio, Enrique Raya, Alba Pérez, Raquel Hernández, Sara Manrique, Mercedes Núñez, Silvia Díaz-Cerezo, Sebastián Moyano, Alessandra Lacetera, Rosario García-Vicuña
Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study. Advances in therapy (2023)
Salvador Blanch, Juan Miguel Gil-Gil, Miriam Arumí, Elena Aguirre, Miguel Ángel Seguí Palmer, Manuel Atienza, Silvia Díaz-Cerezo, Alberto Molero, José Manuel Cervera, Joaquín Gavilá
Observational study of HR+/HER2- metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Miriam Rubio-de Santos, Esther Artime, Natalia Duque, Silvia Díaz-Cerezo, Erik Spaepen, Ágata Carreño, Alberto Fernández
Profile of Patients with Diabetes Treated with Insulin Lispro 200 U/ml: A Real-World Study from Spain. Diabetes therapy : research, treatment and education of diabetes and related disorders 13 (6) (2022)
Federico Longo, Mónica Jorge, Ricardo Yaya, Ana Fernández Montes, Nieves Martínez Lago, Elena Brozos, Jorge Aparicio, Guillermo Quintero, Eduardo Ceballos, Elvira Buxó, Ana Maria Lopez, Maria Luz Pellón, Raquel Molina, Laura Diaz-Paniagua, Paula Cerdà, Pedro Lopez Leiva, Alfonso Martín Carnicero, Antía Cousillas, Lorena Paris, Beatriz García-Paredes, Carlos Romero, María Ortega, Alberto Molero, Sergio de la Torre, Min-Hua Jen, Silvia Díaz-Cerezo
Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study. Future oncology (London, England) 17 (14) (2021)